Bio-TechneTECHEarnings & Financial Report
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Revenue
$276.9M
Gross Profit
$185.2M
Operating Profit
$55.9M
Net Profit
$51.0M
Gross Margin
66.9%
Operating Margin
20.2%
Net Margin
18.4%
YoY Growth
2.7%
EPS
$0.31
Financial Flow
Bio-Techne Q3 2023 Financial Summary
Bio-Techne reported revenue of $276.9M for Q3 2023, with a net profit of $51.0M (18.4% margin). Cost of goods sold was $91.7M, operating expenses totaled $129.3M.
Key Financial Metrics
| Total Revenue | $276.9M |
|---|---|
| Net Profit | $51.0M |
| Gross Margin | 66.9% |
| Operating Margin | 20.2% |
| Report Period | Q3 2023 |
Bio-Techne Annual Revenue by Year
Bio-Techne annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.2B |
| 2023 | $1.1B |
| 2022 | $1.1B |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $303.4M | $289.5M | $297.0M | $316.2M | $316.2M | $286.6M | $295.9M | $295.9M |
| YoY Growth | 3.2% | 4.5% | 9.0% | 4.2% | 4.2% | -1.0% | -0.4% | -6.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.70B | $2.74B | $2.67B | $2.64B | $2.56B | $2.53B | $2.52B | $2.52B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $2.07B | $2.14B | $2.08B | $2.02B | $1.92B | $1.97B | $2.01B | $2.01B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $75.5M | $63.9M | $84.3M | $41.1M | $98.2M | $27.6M | $82.4M |
Other Health Care Companies
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
CRL
Charles River Laboratories
Revenue
$994.2M
Net Profit
$-276.6M
DHR
Danaher Corporation
Revenue
$6.1B
Net Profit
$908.0M
IQV
IQVIA
Revenue
$4.4B
Net Profit
$514.0M
MTD
Mettler Toledo
Revenue
$1.1B
Net Profit
$285.8M
TMO
Thermo Fisher Scientific
Revenue
$11.1B
Net Profit
$1.6B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B